Clinical Trials | December 07, 2025
Bayer launches phase III trial testing Mirena for uterine condition with no treatments
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
MRI is particularly valuable in pediatric care due to its non-invasive nature
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
